Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
30 31 Next >
The 7 Most Undervalued Stocks to Buy in February 2023
Tickers AMZN CTSH FANG GLNG
Tags Stocks to Buy AMZN REGN
From InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Tickers ABCL BNTX CMRX ITOS
Tags CMRX BNTX NASDAQ:CMRX,NASDAQ:ITOS,NASDAQ:BNTX,NASDAQ:VIR,NASDAQ:MRNA,NASDAQ:ABCL,NASDAQ:REGN
From InvestorPlace
Regeneron Pharmaceuticals's Earnings Outlook
Tickers REGN
Tags Benzinga Market News REGN
From Benzinga
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
Tickers BIIB CHTR CTSH INTC
Tags REGN Stocks to Buy CTSH
From InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
Tickers REGN
Tags Earnings Market News REGN
From Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags EBS Biotech Market News
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
Tickers BEAM BIIB CLLS CRSP
Tags Stocks to Buy CRSP REGN
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
Tickers ACN ATER AXTA AZEK
Tags ACN LYFT VRNS
From Benzinga
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
Tickers REGN SNY
Tags Health Care Benzinga News
From Benzinga
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags REGN Market News BZI/AAR
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
Tickers AAPL AMD AMGN AMZN
Tags TXN GOOGL LCRX
From Benzinga
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
Tickers ELV REGN SNY
Tags SNY Market News REGN
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
Tickers ACGL AFG AIG AJG
Tags TRV ACGL PAVM
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
Tickers REGN
Tags Dividends Benzinga News
From Benzinga
Analyst Ratings for Regeneron Pharmaceuticals
Tickers REGN
Tags REGN BZI/AAR Market News
From Benzinga
Check Out What Whales Are Doing With REGN
Tickers REGN
Tags Markets REGN Market News
From Benzinga
Check Out What Whales Are Doing With REGN
Tickers REGN
Tags Options BZI/UOA Market News
From Benzinga
What This Drug News Could Mean for Sanofi Shareholders
Tickers REGN SNY
Tags Recent Press Releases REGN Market News
From Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
Tickers ABT AMGN BAC BMY
Tags REGN Stocks to Buy HZNP
From InvestorPlace
CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker
Tickers CTMX MRNA REGN
Tags General REGN Movers
From Benzinga
3 Growth Stocks That Could Rocket Higher in 2023
Tickers ALNY QURE REGN
Tags QURE ALNY Market News
From Motley Fool
Jim Cramer Says He's 'Still Feeling Good' About These 5 Stocks From 'Mutilated' Nasdaq
Tickers AEP DLTR PEP PG
Tags DLTR PEP Analyst Color
From Benzinga
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
Tickers AMGN CVS REGN
Tags REGN Recent Press Releases CVS
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Biotech CDTX Market News
From Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
Tickers AMGN AZN HZNP JNJ
Tags NVO Recent Press Releases AMGN
From Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
Tickers AAL AAPL AMC AMZN
Tags NIO VBINX REGN
From MarketWatch
2 Best Biotech Stocks to Buy Right Now
Tickers AMGN AZN REGN SNY
Tags Recent Press Releases REGN Market News
From Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
Tickers REGN SNY
Tags News Eurasia Benzinga
From Benzinga
Regeneron Reveals An Early Cut Data From Follicular Lymphoma Study At ASH Meeting
Tickers REGN
Tags Market News General REGN
From Benzinga
Regeneron Highlights Its First Phase 2 Data To Build Case In CD20xC3 Bispecific Space
Tickers REGN
Tags Biotech Large Cap Briefs
From Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.